Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor–specified peripheral niche constraints
Junko Nishio(Joslin Diabetes Center), Christophe Benoıst(Harvard University)
Cited by 62
Related Papers
Antigen persistence is required throughout the expansion phase of a CD4+ T cell response
|The Journal of Experimental Medicine|2005|267
Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3
|Proceedings of the National Academy of Sciences|2015|66
Activation of adenosine receptor A2a by gut symbionts promotes immune tolerance
|Research Square|2021|0